TALSTourmaline Bio Inc


$ 15.68 $ -0.32 (-2 %)    

Friday, 26-Apr-2024 15:59:53 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 15.68
$ 15.88
$ 15.68 x 300
$ 15.76 x 200
$ 15.55 - $ 16.28
$ 9.18 - $ 48.31
360,260
na
na
$ 1.67
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-talaris-therapeutics-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket

Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. B...

 talaris-therapeutics-on-sept-22-co-got-purported-notice-of-material-breach-from-immunofree-alleging-that-co-breached-provision-of-apa-june-28-on-oct-6-co-and-immunofree-executed-binding-settlement-agreement-pursuant-to-which-the-co-to-pay-immunofree-4m

-Reuters

 new-york-blood-center-enterprises-acquires-commercial-scale-cell--gene-therapy-development-and-manufacturing-facilities-from-talaris-therapeutics-no-financial-terms-disclosed

New York Blood Center Enterprises (NYBCe) and Talaris Therapeutics, Inc. (NASDAQ:TALS) ("Talaris") announced today NYBC...

 immunofree-inc-has-acquired-talaris-therapeutics-incs-tolerance-business-no-financial-terms-disclosed

ImmunoFree, Inc. announced today that it has acquired all right to FCR001, a cellular therapy product, and the sponsorship of t...

 crude-oil-down-over-4-innovative-eyewear-shares-plummet

U.S. stocks traded mostly higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Thursday. T...

 why-avid-bioservices-shares-are-trading-lower-by-over-14-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition o...

 nasdaq-rises-70-points-aeglea-biotherapeutics-shares-spike-higher

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 70 points on Thursday. The Dow traded ...

 why-talaris-therapeutics-stock-is-shooting-higher-today

Talaris Therapeutics Inc (NASDAQ: TALS) and Tourmaline Bio, Inc have entered into a definitive agreement for a merger in an all...

 us-stocks-lower-following-initial-jobless-claims-report

U.S. stocks traded lower this morning, following the release of jobless claims data. Following the market opening Thursday, th...

 talaris-therapeutics-and-tourmaline-bio-have-agreed-to-combine-in-an-all-stock-transaction-the-combined-company-will-focus-on-advancing-tourmalines-lead-program-tour006-for-thyroid-eye-disease-and-atherosclerotic-cardiovascular-disease

Upon completion of the Merger, the combined company will operate under the name Tourmaline Bio, Inc. and trade on the Nasdaq un...

 talaris-therapeutics-says-ceo-scott-requadt-will-be-leaving-as-part-of-planned-workforce-reduction-announced-previously

Talaris has appointed Mary Kay Fenton as interim Chief Executive Officer and President effective as of today.

 top-5-health-care-stocks-that-could-sink-your-portfolio-this-quarter

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION